Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Xi'an International Medical Center Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients with mild and severe COVID-19 confirmed according to the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7) that was issued by the National Health Commission & State Administration of Traditional Chinese Medicine; 2. Patients with suspected COVID-19 who meet one of the following pathogenic or serological evidence are also confirmed infected with the virus: a) COVID-19 nucleic acid test positive, as confirmed by real-time fluorescence RT-PCR detection; b) viral gene sequencing is highly homologous with the known COVID-19; c) serum test positive for both COVID-19 specific IgM and IgG antibodies; d) serum IgG antibody turns positive from negative or IgG antibody level in the recovering phase rises four times or higher than in the acute phase; 3. Patients with moderate COVID-19 have fever and respiratory symptoms and present with the imaging features of coronavirus disease; 4. Subjects will be considered developing severe COVID-19 if one of the following conditions occur: dyspnea, respiratory >=30 beats/minute, blood oxygen saturation 50% within 24 to 48 hours 5. Aged > 18 years; 6. Provision of written informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with critical COVID-19 presenting with shock, acute respiratory distress syndrome, multiple organ failure; (2) Patients with mild COVID-19; (3) Pregnant or lactating woman; (4) Upon the investigators judgment, patients had the diseases that possibly influence patient participation in this study or study outcomes (such as malignant disease, autoimmune disease, severe malnutrition, liver and kidney disease, blood disease, nervous system disease, endocrine diseases) or currently suffer from the diseases that seriously affect the immune system (such as human immunodeficiency virus infection) or blood system, or splenectomy/organ transplantation; (5) Upon the request of the investigators or sponsors, patients with other acute malignant or chronic disease or mental disorder are not suitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery time; | — |
Secondary
| Measure | Time frame |
|---|---|
| The rate and time of disappearance of major symptoms;The rate of conversion from COVID-19 positive to COVID-19 negative;The time and rate of obvious improvement as shown on chest CT scans relative to admission;Blood gas analysis indexes;Laboratory test indicators;Change in immune indexes;Ultrasound examination of the urinary system; | — |
Countries
China
Contacts
Public ContactXijing He
Xi'an International Medical Center Hospital
Outcome results
None listed